Selected research
Industry Growth & Trends
Global Genetic Testing For Neurological Disorders Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Genetic Testing For Neurological Disorders market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Genetic Testing For Neurological Disorders market include Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, Quest Diagnostics, MedGenome Labs, GeneDx and Connecticut Children's, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genetic Testing For Neurological Disorders market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genetic Testing For Neurological Disorders market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetic Testing For Neurological Disorders market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetic Testing For Neurological Disorders.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Genetic Testing For Neurological Disorders market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genetic Testing For Neurological Disorders Market by Company
Illumina
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Mayo Clinic
Quest Diagnostics
MedGenome Labs
GeneDx
Connecticut Children's
Labcorp (Invitae/MNG Laboratories)
Genetic Testing For Neurological Disorders Segment by Type
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Genetic Testing For Neurological Disorders Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Genetic Testing For Neurological Disorders Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Testing For Neurological Disorders market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetic Testing For Neurological Disorders and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Testing For Neurological Disorders.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Genetic Testing For Neurological Disorders companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Exome Sequencing
- Whole Genome Sequencing
- RNA Sequencing
- General DNA Testing
Applications
- Hospitals
- Specialty Clinics
- Diagnostics Laboratories
Companies covered
- Illumina
- CENTOGENE
- Victorian Clinical Genetics Services
- PacBio
- Mayo Clinic
- Quest Diagnostics
- MedGenome Labs
- GeneDx
- Connecticut Children's
- Labcorp (Invitae/MNG Laboratories)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Genetic Testing For Neurological Disorders Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Genetic Testing For Neurological Disorders Market Size by Region (2021-2032)
- 1.4.1 Global Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
- 1.4.2 Global Genetic Testing For Neurological Disorders Market Size by Region (2027-2032)
- 1.5 Key Regions Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 1.5.1 North America Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032)
- 1.5.4 South America Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032)
2 Genetic Testing For Neurological Disorders Market by Type
- 2.1 Type Introduction
- 2.1.1 Exome Sequencing
- 2.1.2 Whole Genome Sequencing
- 2.1.3 RNA Sequencing
- 2.1.4 General DNA Testing
- 2.2 Global Genetic Testing For Neurological Disorders Market Size by Type
- 2.2.1 Global Genetic Testing For Neurological Disorders Market Size Overview by Type (2021-2032)
- 2.2.2 Global Genetic Testing For Neurological Disorders Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Genetic Testing For Neurological Disorders Market Size Forecasted by Type (2027-2032)
- 2.3 Global Genetic Testing For Neurological Disorders Market Size by Regions
- 2.3.1 North America Genetic Testing For Neurological Disorders Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Genetic Testing For Neurological Disorders Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Genetic Testing For Neurological Disorders Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Genetic Testing For Neurological Disorders Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Genetic Testing For Neurological Disorders Market Size Breakdown by Type (2021-2026)
3 Genetic Testing For Neurological Disorders Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Specialty Clinics
- 3.1.3 Diagnostics Laboratories
- 3.2 Global Genetic Testing For Neurological Disorders Market Size by Application
- 3.2.1 Global Genetic Testing For Neurological Disorders Market Size Overview by Application (2021-2032)
- 3.2.2 Global Genetic Testing For Neurological Disorders Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Genetic Testing For Neurological Disorders Market Size Forecasted by Application (2027-2032)
- 3.3 Global Genetic Testing For Neurological Disorders Market Size by Regions
- 3.3.1 North America Genetic Testing For Neurological Disorders Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Genetic Testing For Neurological Disorders Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Genetic Testing For Neurological Disorders Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Genetic Testing For Neurological Disorders Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Genetic Testing For Neurological Disorders Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Genetic Testing For Neurological Disorders Industry Trends
- 4.2 Genetic Testing For Neurological Disorders Industry Drivers
- 4.3 Genetic Testing For Neurological Disorders Industry Opportunities and Challenges
- 4.4 Genetic Testing For Neurological Disorders Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Genetic Testing For Neurological Disorders Revenue (2021-2026)
- 5.2 Global Genetic Testing For Neurological Disorders Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Genetic Testing For Neurological Disorders Key Company Headquarters & Area Served
- 5.4 Global Genetic Testing For Neurological Disorders Company, Product Type & Application
- 5.5 Global Genetic Testing For Neurological Disorders Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Genetic Testing For Neurological Disorders Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Genetic Testing For Neurological Disorders Players Market Share by Revenue in 2025
- 5.6.3 2025 Genetic Testing For Neurological Disorders Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Illumina Genetic Testing For Neurological Disorders Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 CENTOGENE
- 6.2.1 CENTOGENE Company Information
- 6.2.2 CENTOGENE Business Overview
- 6.2.3 CENTOGENE Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CENTOGENE Genetic Testing For Neurological Disorders Product Portfolio
- 6.2.5 CENTOGENE Recent Developments
- 6.3 Victorian Clinical Genetics Services
- 6.3.1 Victorian Clinical Genetics Services Company Information
- 6.3.2 Victorian Clinical Genetics Services Business Overview
- 6.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Portfolio
- 6.3.5 Victorian Clinical Genetics Services Recent Developments
- 6.4 PacBio
- 6.4.1 PacBio Company Information
- 6.4.2 PacBio Business Overview
- 6.4.3 PacBio Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 PacBio Genetic Testing For Neurological Disorders Product Portfolio
- 6.4.5 PacBio Recent Developments
- 6.5 Mayo Clinic
- 6.5.1 Mayo Clinic Company Information
- 6.5.2 Mayo Clinic Business Overview
- 6.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mayo Clinic Genetic Testing For Neurological Disorders Product Portfolio
- 6.5.5 Mayo Clinic Recent Developments
- 6.6 Quest Diagnostics
- 6.6.1 Quest Diagnostics Company Information
- 6.6.2 Quest Diagnostics Business Overview
- 6.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Quest Diagnostics Genetic Testing For Neurological Disorders Product Portfolio
- 6.6.5 Quest Diagnostics Recent Developments
- 6.7 MedGenome Labs
- 6.7.1 MedGenome Labs Company Information
- 6.7.2 MedGenome Labs Business Overview
- 6.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 MedGenome Labs Genetic Testing For Neurological Disorders Product Portfolio
- 6.7.5 MedGenome Labs Recent Developments
- 6.8 GeneDx
- 6.8.1 GeneDx Company Information
- 6.8.2 GeneDx Business Overview
- 6.8.3 GeneDx Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GeneDx Genetic Testing For Neurological Disorders Product Portfolio
- 6.8.5 GeneDx Recent Developments
- 6.9 Connecticut Children's
- 6.9.1 Connecticut Children's Company Information
- 6.9.2 Connecticut Children's Business Overview
- 6.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Connecticut Children's Genetic Testing For Neurological Disorders Product Portfolio
- 6.9.5 Connecticut Children's Recent Developments
- 6.10 Labcorp (Invitae/MNG Laboratories)
- 6.10.1 Labcorp (Invitae/MNG Laboratories) Company Information
- 6.10.2 Labcorp (Invitae/MNG Laboratories) Business Overview
- 6.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Portfolio
- 6.10.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
7 North America
- 7.1 North America Genetic Testing For Neurological Disorders Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 7.3 North America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Genetic Testing For Neurological Disorders Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 8.3 Europe Genetic Testing For Neurological Disorders Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Genetic Testing For Neurological Disorders Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Genetic Testing For Neurological Disorders Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Genetic Testing For Neurological Disorders Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 10.3 South America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Genetic Testing For Neurological Disorders Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Genetic Testing For Neurological Disorders Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst